Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 5/2009

01-05-2009

Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system

Authors: Takashi Maeda, Jaesung Hong, Kozo Konishi, Takanori Nakatsuji, Takefumi Yasunaga, Yo-ichi Yamashita, Akinobu Taketomi, Kazuhiro Kotoh, Munechika Enjoji, Hideaki Nakashima, Kazuo Tanoue, Yoshihiko Maehara, Makoto Hashizume

Published in: Surgical Endoscopy | Issue 5/2009

Login to get access

Abstract

Background

As minimally invasive treatments for liver cancers, percutaneous ablation therapies represent a valid alternative to liver resections, especially in patients with poor liver function. Recently, image-guided surgical and interventional procedures using open magnetic resonance imaging (MRI) have been introduced.

Methods

We performed percutaneous ablation therapy for 51 nodules of liver cancer in 34 patients using a navigation system based on open MRI. During the ablation therapy, the ultrasonography (US) probe, needle, and tumor were displayed on the MR image. Immediately after the procedure, the therapeutic effect was evaluated by open MRI.

Results

In all cases, percutaneous puncture into the tumors was successful, even in the case of tumor undetectable by US. Mean fiducial registration error was approximately 3 mm. MR images captured after the procedure clearly demonstrated the ablated area. No mortality or major complications occurred, except for mild hemorrhage, pyrexia, and ascites.

Conclusions

We developed a novel navigation system integrating US and MR images using open MRI for percutaneous ablation therapy of liver cancers. The presented system allows a safe and accurate approach to liver cancers, especially certain tumors that cannot be adequately visualized by US, and an evaluation of therapeutic results immediately after the procedures.
Literature
1.
Omata M, Tateishi R, Yoshida H, Shiina S (2004) Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 127:S159–S166PubMedCrossRef
2.
Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma An analysis of 1000 cases. Cancer 103:1201–1209PubMedCrossRef
3.
Kudo M (2004) Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 39:205–214PubMedCrossRef
4.
Seki T, Wakabayashi M, Nakagawa T et al (1999) Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol 94:322–327PubMedCrossRef
5.
Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J (1999) Hepatectomy for hepatocellular carcinoma: the surgeon’s role in long-term survival. Arch Surg 134:1124–1130PubMedCrossRef
6.
Vivarelli M, Guglielmi A, Ruzzenente A et al (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240:102–107PubMedCrossRef
7.
Arii S, Yamaoka Y, Futagawa S et al (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 32:1224–1229PubMedCrossRef
8.
Befler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609–1619CrossRef
9.
Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H (2004) Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 183:153–156PubMed
10.
Meloni MF, Goldberg SN, Livraghi T et al (2001) Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR 177:375–380PubMed
11.
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic–pathologic correlation. Cancer 88:2452–2463PubMedCrossRef
12.
Numata K, Tanaka K, Kiba T et al (2001) Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO2-enhanced sonography. AJR 177:789–798PubMed
13.
Rode A, Bancel B, Douek P et al (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327–336PubMedCrossRef
14.
Martin RC, Husheck S, Cr Scoggins, McMasters KM (2006) Intraoperative magnetic resonance imaging for ablation of hepatic tumors. Surg Endosc 20:1536–1542PubMedCrossRef
15.
Kurumi Y, Tani T, Naka S, Shiomi H, Abe H, Endo Y, Morikawa S (2007) MR-guided microwave ablation for malignancies. Int J Clin Oncol 12:85–93PubMedCrossRef
16.
Hong J, Nakashima H, Konishi K, Ieiri S, Tanoue K, Nakamuta M, Hashizume M (2006) Interventional navigation for abdominal therapy based on simultaneous use of MRI and ultrasound. Med Bio Eng Comput 44:1127–1134CrossRef
17.
Silverman SG, Tuncali K, Adams DF, vanSonnenberg E, Zou KH, Kacher DF, Morrison PR, Jolesz FA (2000) MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217:657–664PubMed
18.
Blanco RT, Ojala R, Kariniemi J, Perälä J, Tervonen O (2005) Interventional and intraoperative MRI at low field scanner—a review. Eur J Radiol 56:130–142PubMedCrossRef
19.
Gering DT, Nabavi A, Kikinis R, Hata N, O’Donnell LJ, Grimson WE, Jolesz FA, Black PM, Wells WM III (2001) An integrated visualization system for surgical planning and guidance using image fusion and an open MR. J Magn Reson Imaging 13:967–975PubMedCrossRef
20.
Samset E, Talsma A, Kintel M et al (2002) A virtual environment for surgical image guidance in intraoperative MRI. Comput Aided Surg 7:187–196PubMedCrossRef
21.
Curley SA, Izzo F, Ellis LM et al (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391PubMedCrossRef
22.
Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y, Terano A (1991) Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 68:1524–1530
23.
Shiina S, Imamura M, Omata M (1997) Percutaneous ethanol injection therapy (PEIT) for malignant liver neoplasms. Semin Interv Radiol 14:295–303
24.
Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE (1999) Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 353:1676–1677PubMedCrossRef
25.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451PubMedCrossRef
26.
Mulier S, Mulier P, Ni Y et al (2002) Complications of radiofrequency coagulation of liver tumors. Br J Surg 89:1206–1222PubMedCrossRef
27.
Rhim H, Dodd GD 3rd (1999) Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 5:221–229CrossRef
28.
Ishii H, Okada S, Nose H et al (1996) Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 77:1792–1796PubMedCrossRef
29.
Sato S, Shiratori Y, Imamura M et al (2001) Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J Hepatol 35:225–234PubMedCrossRef
30.
Hasegawa S, Yamasaki N, Hiwaki T et al (1999) Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 86:1682–1690PubMedCrossRef
Metadata
Title
Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system
Authors
Takashi Maeda
Jaesung Hong
Kozo Konishi
Takanori Nakatsuji
Takefumi Yasunaga
Yo-ichi Yamashita
Akinobu Taketomi
Kazuhiro Kotoh
Munechika Enjoji
Hideaki Nakashima
Kazuo Tanoue
Yoshihiko Maehara
Makoto Hashizume
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 5/2009
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-008-0123-6

Other articles of this Issue 5/2009

Surgical Endoscopy 5/2009 Go to the issue

Letter

Which term is better: SILS, SPA, LESS, E-NOTES, or TUES?

Letter

Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma

Letter

Advanced gastric cancer: is laparoscopic gastrectomy safe?

OriginalPaper

Disturbances in the circadian pattern of activity and sleep after laparoscopic versus open abdominal surgery

Letter

Elective laparoscopic diverticular resection

Dynamic Manuscript

Laparoscopic approach to esophageal perforation secondary to pneumatic dilation for achalasia